Fluorodopa F18
Fluorodopa F18 is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Fluorodopa F18. Available dosage form: injection.
Drug Details
- Generic Name
- Fluorodopa F18
- Brand Names
- Fluorodopa F18
- Application Number
- NDA200655
- Sponsor
- THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
- NDC Codes
- 2
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- FLUORODOPA F-18
Indications and Usage
1 INDICATIONS AND USAGE Fluorodopa F 18 Injection is indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations. Fluorodopa F 18 Injection is a radioactive diagnostic agent indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations.